Table 2.
Logistic Regression Analysis of VI in ROP
| All VI | Severe VI | |||
|---|---|---|---|---|
| Odds Ratio | 95% CI | Odds Ratio | 95% CI | |
| Treatment | ||||
| No treatment | Reference | Reference | ||
| Laser/Cryo | 6.17 | 3.13–12.19 | 5.73 | 2.24–14.70 |
| anti-VEGF | 13.80 | 2.90–65.66 | 26.50 | 5.04–139.29 |
| Surgery | 132.10 | 67.14–259.92 | 208.75 | 84.72–514.39 |
| Female sex | 0.80 | 0.54–1.18 | 0.68 | 0.42–1.09 |
| Birth year | 0.76 | 0.69–0.83 | 0.77 | 0.70–0.86 |
| Birth weight (g) | ||||
| ≥2500 | Reference | Reference | ||
| 1500–2499 | 0.72 | 0.36–1.41 | 1.36 | 0.51–3.65 |
| <1500 | 1.32 | 0.66–2.67 | 2.47 | 0.91–6.73 |
| Ocular comorbidities* | 1.77 | 1.35–2.32 | 1.01 | 0.71–1.45 |
CI, confidence interval; OR, odds ratio.
*
Congenital ocular anomalies, retinal dystrophies, neoplasms, and severe ocular traumas.